Navigation Links
Regional Biotech Association Warns Legislation Would Make VT Least Friendly State in Nation for Biotechnology and Life Sciences
Date:4/24/2009

-Testimony To Legislature Calls For Rejection Of Legislation That Will Cost Vermonters Current And Future Jobs-

MONTPELIER, Vt., April 24 /PRNewswire/ -- In testimony to the Legislature and a full page ad in today's Rutland Herald, the region's largest biotechnology association warned that a bill under consideration by the Vermont Legislature will create the most restrictive and onerous regulatory environment for biotechnology growth and development not only in New England, but in the entire nation. S. 48/H. 270 is the subject of a hearing in Montpelier today.

"Plain and simple, this legislation will harm Vermont's biotechnology and life sciences sector and drive jobs away," said Paula Newton, Chair of the New England Biotech Association (NEBA).

NEBA serves as the regional policy and public affairs voice for the biotechnology and biopharmaceutical community, representing state biotech associations, companies, academic institutions, and other organizations consisting of more than 800 entities.

"Vermont already has one of the strictest pharmaceutical marketing disclosure laws in the country, so the onerous regulatory regime contemplated by the Legislation is wholly unnecessary and should be defeated," continued Newton. "Physicians are trusted professionals, and introducing unreasonably broad controls and prohibitions on the interactions between the biopharmaceutical industry and doctors is unwarranted and contrary to health interests of Vermonters who stand to benefit from miracle drugs." She said the legislation would also eliminate existing protections of trade secrets, create an unneeded new state bureaucracy, and drive away research funding by mandating additional disclosure of expenditures.

Four other states, including New England states Maine and Rhode Island, have recently rejected marketing restriction legislation far less extreme than the Vermont bill, declaring the measures as bad policy with negative consequences for the life sciences industry and the jobs it produces. An overly restrictive disclosure law recently passed in Massachusetts --- less strict than the Vermont proposal -- has resulted in a drop in clinical trials and the cancellation of a major medical convention and the associated tourism and tax revenue.

NEBA is a non-profit, member-driven organization comprised of state biotech associations, companies, academic institutions, and other organizations with a collective mission to support and grow the biotechnology industry in New England.

To find out more about NEBA and view a copy of the Rutland Herald ad, visit www.newenglandbiotech.org


'/>"/>
SOURCE New England Biotech Association
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Defeat Autism Now!(R) Regional Conference to be Held in Oklahoma June 13-14, 2009
2. Midwest Research Institute Expands in Kansas to Support Regional Economic Development in Animal Health, Biosecurity, and Bioenergy Sectors
3. Regional Biotech Association Warns Vermont Legislation Could Have Profound Negative Impact
4. Shasta Regional Medical Center Awarded Full Accreditation from the Joint Commission
5. New Regional Biotech Association Formed
6. China Biopharma Reaches Agreement with a Regional Pharma to Launch New Pharmaceutical Products
7. Hcareers.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
8. BioSpace.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
9. JobLoft.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
10. onTargetjobs Announces Acquisition of RegionalHelpWanted.com
11. A Magnetic Gift: Sumter Regional Hospital Receives New MRI as Charitable Donation From Siemens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... /PRNewswire/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic" ... Liver Congress ("ILC") 2017 of the European Association for the ... on the positive effects of PBI-4050 on reduction of ... metabolic syndrome. ... Dr. Lyne Gagnon, Vice-President of R&D Pre-clinical of Prometic "This ...
(Date:4/20/2017)... , April 20, 2017 Dutch philosopher Koert van ... ,Next Nature, at the University of Technology in Eindhoven - has written ... this letter, he calls on humanity to avoid becoming a slave and victim ... ... Dutch philosopher Koert van Mensvoort – founder of the ...
(Date:4/19/2017)... ... April 18, 2017 , ... A number of new instruments ... which is part of the Protein and Cell Analysis Education Webinar Series , ... this technology fits in current and future applications. , Many flow cytometers have ...
(Date:4/19/2017)... ... April 19, 2017 , ... ThermaGenix, the PCR Improvement Company, ... to several other early achievements at ThermaGenix, including the business formation and licensing ... ThermaGenix will use proceeds from the Series A-1 round to:, ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
(Date:3/30/2017)... 30, 2017 Trends, opportunities and forecast in ... by technology (fingerprint, AFIS, iris recognition, facial recognition, hand ... by end use industry (government and law enforcement, commercial ... banking, and others), and by region ( North ... Asia Pacific , and the Rest of ...
(Date:3/24/2017)... 2017 Research and Markets has announced the ... & Trends - Industry Forecast to 2025" report to their ... The Global ... CAGR of around 15.1% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
Breaking Biology News(10 mins):